2020-06-16 Legal Press releases

Intervacc intends to carry out a directed share issue

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE , IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SWITZERLAND, UNITED STATES OF AMERICA OR ANY OTHER JURISDICTION IN ... Read more

2020-06-15 Legal Press releases

Intervacc and the Karolinska Institutet extend contract for the development of innovative animal health vaccines

Stockholm 15 June 2020 - Intervacc AB (publ) and the Karolinska Institute, KI, announce today that they have extended the contract for the development of a new generation of animal health vaccines using recombinant ... Read more

2020-06-11 Legal Press releases

Intervacc appoints international bacteriology expert as Chief Scientific Officer

Stockholm 11 June 2020 – The Swedish biotechnology company Intervacc AB (publ), which is developing modern, effective and safe vaccines for animal health has appointed Dr. Andrew Waller as the new Chief Scientific ... Read more

2020-06-04 Legal Press releases

Positive results from Strangvac clinical trials published in scientific journal Vaccine

Results and analyses from clinical trials on the Strangvac^® vaccine research project have been published online in the leading scientific journal ‘Vaccine’. The article highlights that Strangvac^® ... Read more

2020-03-26 Legal Press releases

Intervacc awarded funding from Vinnova for further development of vaccine against Staphylococcus aureus infections

Stockholm 25 March 2020 - Intervacc AB (publ) will continue the development of its new vaccine against Staphylococcus aureus infections that cause mastitis in dairy cows. The project will be co-financed by Intervacc and ... Read more

2020-03-18 Legal Press releases

The European Medicines Agency confirms that Intervacc’s application for the granting of a Community marketing authorization for Strangvac is complete and correctly submitted

Stockholm March 18, 2020 - Intervacc AB (publ) announces that the European Medicines Agency, EMA, has today confirmed that the company's application for the granting of a Community marketing authorization for Strangvac is ... Read more